PubMed

Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study.

Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, Morard I, Lasser L, Langlet P, Denninger MH, Vidaud D, Condat B, Hadengue A, Primignani M, Garcia-Pagan JC, Janssen HL, Valla D; European Network for Vascular Disorders of the Liver (EN‐Vie)A complete list of EN‐Vie investigators and study investigators appears in the Appendix..

Hepatology. 2009 Aug 31. [Epub ahead of print]PMID: 19821530 [PubMed - as supplied by publisher]Related articles

Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial.

Woltman AM, Ter Borg MJ, Binda RS, Sprengers D, von Blomberg BM, Scheper RJ, Hayashi K, Nishi N, Boonstra A, van der Molen R, Janssen HL.

Antivir Ther. 2009;14(6):809-18.PMID: 19812443 [PubMed - in process]Related articles

Factors that Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa.

Buster EH, Hansen BE, Lau GK, Piratvisuth T, Zeuzem S, Steyerberg EW, Janssen HL.

Gastroenterology. 2009 Sep 6. [Epub ahead of print]PMID: 19737568 [PubMed - as supplied by publisher]Related articles

The Rotterdam Study: 2010 objectives and design update.

Hofman A, Breteler MM, van Duijn CM, Janssen HL, Krestin GP, Kuipers EJ, Stricker BH, Tiemeier H, Uitterlinden AG, Vingerling JR, Witteman JC.

Eur J Epidemiol. 2009;24(9):553-72.PMID: 19728115 [PubMed - indexed for MEDLINE]Related articlesFree article

The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells.

Op den Brouw ML, Binda RS, Geijtenbeek TB, Janssen HL, Woltman AM.

Virology. 2009 Oct 10;393(1):84-90. Epub 2009 Aug 15.PMID: 19683778 [PubMed - indexed for MEDLINE]Related articles

Experimental models for hepatitis C viral infection.

Boonstra A, van der Laan LJ, Vanwolleghem T, Janssen HL.

Hepatology. 2009 Nov;50(5):1646-55.PMID: 19670425 [PubMed - in process]Related articles

Paroxysmal nocturnal hemoglobinuria in Budd-Chiari Syndrome: findings from a cohort study.

Hoekstra J, Leebeek FW, Plessier A, Raffa S, Darwish Murad S, Heller J, Hadengue A, Chagneau C, Elias E, Primignani M, Garcia-Pagan JC, Valla DC, Janssen HL; European Network for Vascular Disorders of the Liver.

J Hepatol. 2009 Oct;51(4):696-706. Epub 2009 Jul 23.PMID: 19664836 [PubMed - in process]Related articles

Etiology, management, and outcome of the Budd-Chiari syndrome.

Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, Hadengue A, Langlet P, Miranda H, Primignani M, Elias E, Leebeek FW, Rosendaal FR, Garcia-Pagan JC, Valla DC, Janssen HL; EN-Vie (European Network for Vascular Disorders of the Liver).

Ann Intern Med. 2009 Aug 4;151(3):167-75.PMID: 19652186 [PubMed - indexed for MEDLINE]Related articles

Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients.

Buster EH, Flink HJ, Simsek H, Heathcote EJ, Sharmila S, Kitis GE, Gerken G, Buti M, de Vries RA, Verhey E, Hansen BE, Janssen HL.

Am J Gastroenterol. 2009 Oct;104(10):2449-57. Epub 2009 Jul 7.PMID: 19584831 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.

Veldt BJ, Poterucha JJ, Watt KD, Wiesner RH, Hay JE, Rosen CB, Heimbach JK, Janssen HL, Charlton MR.

Am J Transplant. 2009 Jun;9(6):1406-13. Epub 2009 May 13.PMID: 19459812 [PubMed - in process]Related articles

Prospects of RNAi and microRNA-based therapies for hepatitis C.

Pan Q, Tilanus HW, Janssen HL, van der Laan LJ.

Expert Opin Biol Ther. 2009 Jun;9(6):713-24. Review.PMID: 19456206 [PubMed - indexed for MEDLINE]Related articles

Treatment with nucleos(t)ide analogues in chronic hepatitis B: where does the road map lead us?

Janssen HL, Reijnders JG.

J Hepatol. 2009 Jul;51(1):1-3. Epub 2009 May 3. No abstract available. PMID: 19443071 [PubMed - indexed for MEDLINE]Related articles

Comments on the EASL practice guidelines for the management of chronic hepatitis B: controversies in interferon-based therapy.

Janssen HL, Buster EH.

J Hepatol. 2009 Jul;51(1):224-6. Epub 2009 Mar 12. No abstract available. PMID: 19410322 [PubMed - indexed for MEDLINE]Related articles

Combined antiviral activity of interferon-alpha and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing.

Pan Q, Henry SD, Metselaar HJ, Scholte B, Kwekkeboom J, Tilanus HW, Janssen HL, van der Laan LJ.

J Mol Med. 2009 Jul;87(7):713-22. Epub 2009 Apr 30.PMID: 19404587 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular liver disorders (II): portal vein thrombosis.

Hoekstra J, Janssen HL.

Neth J Med. 2009 Feb;67(2):46-53. Review.PMID: 19299846 [PubMed - indexed for MEDLINE]Related articlesFree article

Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.

Reijnders JG, Pas SD, Schutten M, de Man RA, Janssen HL.

J Hepatol. 2009 Apr;50(4):674-83. Epub 2008 Dec 29.PMID: 19231002 [PubMed - indexed for MEDLINE]Related articles

Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.

Buster EH, Schalm SW, Janssen HL.

Best Pract Res Clin Gastroenterol. 2008;22(6):1093-108. Review.PMID: 19187869 [PubMed - indexed for MEDLINE]Related articles

Immunology of hepatitis B and hepatitis C virus infections.

Boonstra A, Woltman AM, Janssen HL.

Best Pract Res Clin Gastroenterol. 2008;22(6):1049-61. Review.PMID: 19187866 [PubMed - indexed for MEDLINE]Related articles

On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks.

Reijnders JG, Leemans WF, Hansen BE, Pas SD, de Man RA, Schutten M, Janssen HL.

J Viral Hepat. 2009 Feb;16(2):113-20. Epub 2008 Sep 26.PMID: 19175883 [PubMed - indexed for MEDLINE]Related articles

Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.

Smalberg JH, Spaander MV, Jie KS, Pattynama PM, van Buuren HR, van den Berg B, Janssen HL, Leebeek FW.

Thromb Haemost. 2008 Dec;100(6):1084-8.PMID: 19132234 [PubMed - indexed for MEDLINE]Related articles

Early changes of the portal tract on microcomputed tomography images in a newly-developed rat model for Budd-Chiari syndrome.

Darwish Murad S, Dom VA, Ritman EL, de Groen PC, Beigley PE, Abraham SC, Zondervan PE, Janssen HL.

J Gastroenterol Hepatol. 2008 Oct;23(10):1561-6.PMID: 19120847 [PubMed - indexed for MEDLINE]Related articles

What is on the horizon for treatment of chronic hepatitis C?

Bergmann JF, De Knegt RJ, Janssen HL.

Minerva Med. 2008 Dec;99(6):569-82. Review.PMID: 19034255 [PubMed - indexed for MEDLINE]Related articles

How effective is adefovir dipivoxil plus lamivudine for the treatment of lamivudine-resistant chronic hepatitis B?

Reijnders JG, Janssen HL.

Nat Clin Pract Gastroenterol Hepatol. 2008 Dec;5(12):668-9. Epub 2008 Oct 14. No abstract available. PMID: 18852730 [PubMed]Related articles

Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients.

Stoop JN, Claassen MA, Woltman AM, Binda RS, Kuipers EJ, Janssen HL, van der Molen RG, Boonstra A.

Clin Immunol. 2008 Dec;129(3):419-27. Epub 2008 Sep 26.PMID: 18823821 [PubMed - indexed for MEDLINE]Related articles

Modulation of dendritic cell function by persistent viruses.

Liu B, Woltman AM, Janssen HL, Boonstra A.

J Leukoc Biol. 2009 Feb;85(2):205-14. Epub 2008 Sep 25. Review.PMID: 18818373 [PubMed - indexed for MEDLINE]Related articles

Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome.

Hoekstra J, Janssen HL.

Neth J Med. 2008 Sep;66(8):334-9. Review.PMID: 18809980 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.

Schiff E, Simsek H, Lee WM, Chao YC, Sette H Jr, Janssen HL, Han SH, Goodman Z, Yang J, Brett-Smith H, Tamez R.

Am J Gastroenterol. 2008 Nov;103(11):2776-83. Epub 2008 Aug 21. Erratum in: Am J Gastroenterol. 2009 Feb;104(2):540. PMID: 18721244 [PubMed - indexed for MEDLINE]Related articles

Treatment of chronic hepatitis C virus infection - Dutch national guidelines.

de Bruijne J, Buster EH, Gelderblom HC, Brouwer JT, de Knegt RJ, van Erpecum KJ, Schalm SW, Bakker CM, Zaaijer HL, Janssen HL, Reesink HW; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):311-22. Review. Erratum in: Neth J Med. 2008 Dec;66(11):456. Dosage error in article text. PMID: 18663263 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of chronic hepatitis B virus infection - Dutch national guidelines.

Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):292-306. Review.PMID: 18663260 [PubMed - indexed for MEDLINE]Related articlesFree article

Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus.

Op den Brouw ML, Binda RS, van Roosmalen MH, Protzer U, Janssen HL, van der Molen RG, Woltman AM.

Immunology. 2009 Feb;126(2):280-9. Epub 2008 Jun 28.PMID: 18624732 [PubMed - indexed for MEDLINE]Related articles

TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.

Garcia-Pagán JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, Abraldes JG, Olliff S, Nicolini A, Luca A, Primignani M, Janssen HL, Valla D, Elias E, Bosch J; Budd-Chiari Syndrome-Transjugular Intrahepatic Portosystemic Shunt Group.

Gastroenterology. 2008 Sep;135(3):808-15. Epub 2008 May 21.PMID: 18621047 [PubMed - indexed for MEDLINE]Related articles

Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.

Leemans WF, Niesters HG, van der Eijk AA, Janssen HL, Schalm SW, de Man RA.

Eur J Gastroenterol Hepatol. 2008 Aug;20(8):773-7.PMID: 18617782 [PubMed - indexed for MEDLINE]Related articles

Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.

Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, So TM, Feinman SV, Mach T, Akarca US, Schutten M, Tielemans W, van Vuuren AJ, Hansen BE, Janssen HL.

Gastroenterology. 2008 Aug;135(2):459-67. Epub 2008 May 15.PMID: 18585385 [PubMed - indexed for MEDLINE]Related articles

Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen.

Sprengers D, Sillé FC, Derkow K, Besra GS, Janssen HL, Schott E, Boes M.

Gastroenterology. 2008 Jun;134(7):2132-43. Epub 2008 Feb 21.PMID: 18549881 [PubMed - indexed for MEDLINE]Related articles

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.

Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL.

Hepatology. 2008 Jun;47(6):1856-62.PMID: 18506898 [PubMed - indexed for MEDLINE]Related articles

Branched oligosaccharide structures on HBV prevent interaction with both DC-SIGN and L-SIGN.

Op den Brouw ML, de Jong MA, Ludwig IS, van der Molen RG, Janssen HL, Geijtenbeek TB, Woltman AM.

J Viral Hepat. 2008 Sep;15(9):675-83. Epub 2008 May 14.PMID: 18482282 [PubMed - indexed for MEDLINE]Related articles

ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B.

ter Borg MJ, Hansen BE, Bigot G, Haagmans BL, Janssen HL.

J Clin Virol. 2008 Jun;42(2):160-4. Epub 2008 Mar 24.PMID: 18359663 [PubMed - indexed for MEDLINE]Related articles

Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome.

Darwish Murad S, Luong TK, Pattynama PM, Hansen BE, van Buuren HR, Janssen HL.

Liver Int. 2008 Feb;28(2):249-56.PMID: 18251982 [PubMed - indexed for MEDLINE]Related articles

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.

Kiladjian JJ, Cervantes F, Leebeek FW, Marzac C, Cassinat B, Chevret S, Cazals-Hatem D, Plessier A, Garcia-Pagan JC, Darwish Murad S, Raffa S, Janssen HL, Gardin C, Cereja S, Tonetti C, Giraudier S, Condat B, Casadevall N, Fenaux P, Valla DC.

Blood. 2008 May 15;111(10):4922-9. Epub 2008 Feb 4.PMID: 18250227 [PubMed - indexed for MEDLINE]Related articlesFree article

Effectiveness of health-related quality-of-life measurement in clinical practice: a prospective, randomized controlled trial in patients with chronic liver disease and their physicians.

Gutteling JJ, Darlington AS, Janssen HL, Duivenvoorden HJ, Busschbach JJ, de Man RA.

Qual Life Res. 2008 Mar;17(2):195-205. Epub 2008 Feb 2.PMID: 18246446 [PubMed - indexed for MEDLINE]Related articlesFree article

Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.

ter Borg MJ, Hansen BE, Herrmann E, Zeuzem S, Cakaloglu Y, Karayalcin S, Flisiak R, van' t Veen A, de Man RA, Schalm SW, Janssen HL, Haagmans BL; HBV 99-01 Study Group.

Antivir Ther. 2007;12(8):1285-94.PMID: 18240868 [PubMed - indexed for MEDLINE]Related articles

Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study.

Spaander MC, Darwish Murad S, van Buuren HR, Hansen BE, Kuipers EJ, Janssen HL.

Gastrointest Endosc. 2008 May;67(6):821-7. Epub 2008 Jan 18.PMID: 18206153 [PubMed - indexed for MEDLINE]Related articles

Potency of tenofovir in chronic hepatitis B: mono or combination therapy?

Reijnders JG, Janssen HL.

J Hepatol. 2008 Mar;48(3):383-6. Epub 2007 Dec 31. No abstract available. PMID: 18191272 [PubMed - indexed for MEDLINE]Related articles

Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression.

Leemans WF, Janssen HL, Niesters HG, de Man RA.

J Viral Hepat. 2008 Feb;15(2):108-14.PMID: 18184193 [PubMed - indexed for MEDLINE]Related articles

Review article: The management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults.

Spaander VM, van Buuren HR, Janssen HL.

Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:203-9. Review. Erratum in: Aliment Pharmacol Ther. 2008 Mar 15;27(6):528-9. PMID: 18081663 [PubMed - indexed for MEDLINE]Related articlesFree article

Exacerbation of chronic hepatitis B infection after delivery.

ter Borg MJ, Leemans WF, de Man RA, Janssen HL.

J Viral Hepat. 2008 Jan;15(1):37-41.PMID: 18088243 [PubMed - indexed for MEDLINE]Related articles

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL.

Ann Intern Med. 2007 Nov 20;147(10):677-84.PMID: 18025443 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis B.

Sprengers D, Stoop JN, Binda RS, Kusters JG, Haagmans BL, Carotenuto P, Artsen A, van der Molen RG, Janssen HL.

Antivir Ther. 2007;12(7):1087-96.PMID: 18018767 [PubMed - indexed for MEDLINE]Related articles

Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders.

Bergmann JF, Vrolijk JM, van der Schaar P, Vroom B, van Hoek B, van der Sluys Veer A, de Vries RA, Verhey E, Hansen BE, Brouwer JT, Janssen HL, Schalm SW, de Knegt RJ.

Liver Int. 2007 Nov;27(9):1217-25.PMID: 17919233 [PubMed - indexed for MEDLINE]Related articles

In vivo immunization in combination with peg-interferon for chronic hepatitis B virus infection.

Sprengers D, van der Molen RG, Binda R, Kusters JG, de Man RA, Niesters HG, Schalm SW, Janssen HL.

J Viral Hepat. 2007 Oct;14(10):743-9.PMID: 17875010 [PubMed - indexed for MEDLINE]Related articles